Data / Form D filings / GYRE THERAPEUTICS, INC.
GYRE THERAPEUTICS, INC.: Form D filing
GYRE THERAPEUTICS, INC., a pharmaceuticals company in San Diego, CA, filed a Form D with the SEC in 2023. The latest, on November 13, 2023, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12770 High Bluff Drive, Suite 150, San Diego, CA, 92130
- Phone
- (619) 949-3681
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1124105
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | New notice | $5,000,000 | $5,000,000 | 1 | Oct 30, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Han G. Ying | Director | |
| Usman G. Nassim | Director | |
| Weiguo Yu | Executive Officer | |
| Renate Parry | Director | |
| Ying Luo | Director | |
| Songjiang Ma | Director, Executive Officer | |
| Thomas Eastling | Director | |
| Gordon G. Carmichael | Director | |
| Ruoyu Chen | Executive Officer | |
| Charles Wu | Director, Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what GYRE THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.